PMID: 16639923Apr 28, 2006Paper

Therapy of patients with heart failure--do we owe anything to our patients?

Casopís lékar̆ů c̆eských
J Bultas

Abstract

In hardly any other field of treatment of a chronic disease more evident progress can be seen than in the therapy of hearth failure. Till the end of eighties of the previous century we were not able to influence the adverse development of the disease. With the critical prognosis, chronic heart disease represents more serious case than majority of tumours. In the meantime the only approach to decrease mortality has been modulation of the maladaptively activated regulatory mechanisms--the rennin, angiotensin, aldosteron axis and the sympatoadrenal system. During the previous decades we became witnesses of the development of new pharmacologic approaches aimed at the heart failure: New inotropics (e.g. lavosimendan and pomobendan) have been introduced, effects of anti-arrhythmiatics (amiodaron, dronedaron and others) and metabolically active drugs (trimetazidine, ranolazine and others) has been tested as well as methods decreasing fluid retention (aquaarretics) has been used. It is too early to conclude that such ethiopathogenetical approach can decrease mortality or morbidity. Along with the advance of new possibilities to interfere directly with the pathogenesis of the heart failure, approaches aimed at the treatment of deteriora...Continue Reading

Related Concepts

Related Feeds

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.